188 related articles for article (PubMed ID: 24014300)
1. Immunotherapies in CLL.
Park JH; Brentjens RJ
Adv Exp Med Biol; 2013; 792():241-57. PubMed ID: 24014300
[TBL] [Abstract][Full Text] [Related]
2. Advances in chimeric antigen receptor immunotherapy for chronic lymphocytic leukemia.
Riches JC; Gribben JG
Discov Med; 2013 Dec; 16(90):295-302. PubMed ID: 24333409
[TBL] [Abstract][Full Text] [Related]
3. Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect.
Bachireddy P; Ennis C; Nguyen VN; Gohil SH; Clement K; Shukla SA; Forman J; Barkas N; Freeman S; Bavli N; Elagina L; Leshchiner I; Mohammad AW; Mathewson ND; Keskin DB; Rassenti LZ; Kipps TJ; Brown JR; Getz G; Ho VT; Gnirke A; Neuberg D; Soiffer RJ; Ritz J; Alyea EP; Kharchenko PV; Wu CJ
Sci Transl Med; 2020 Sep; 12(561):. PubMed ID: 32938797
[TBL] [Abstract][Full Text] [Related]
4. Cellular immune therapy for chronic lymphocytic leukemia.
Kater AP; van Oers MH; Kipps TJ
Blood; 2007 Oct; 110(8):2811-8. PubMed ID: 17638850
[TBL] [Abstract][Full Text] [Related]
5. Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia.
Kovalovsky D; Yoon JH; Cyr MG; Simon S; Voynova E; Rader C; Wiestner A; Alejo J; Pittaluga S; Gress RE
Leukemia; 2021 Sep; 35(9):2581-2591. PubMed ID: 33633313
[TBL] [Abstract][Full Text] [Related]
6. How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?
Zhang M; Huang H
Front Immunol; 2020; 11():611710. PubMed ID: 33384696
[TBL] [Abstract][Full Text] [Related]
7. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M
Front Immunol; 2020; 11():594556. PubMed ID: 33312177
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease.
Boyiadzis M; Foon KA; Pavletic S
Expert Opin Biol Ther; 2007 Dec; 7(12):1789-97. PubMed ID: 18034645
[TBL] [Abstract][Full Text] [Related]
9. High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.
Machaczka M; Johansson JE; Remberger M; Hallböök H; Lazarevic VLj; Wahlin BE; Omar H; Wahlin A; Juliusson G; Kimby E; Hägglund H
Med Oncol; 2013 Dec; 30(4):762. PubMed ID: 24214180
[TBL] [Abstract][Full Text] [Related]
10. A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs.
Mato A; Porter DL
Blood; 2015 Jul; 126(4):478-85. PubMed ID: 26065655
[TBL] [Abstract][Full Text] [Related]
11. Engaging Cytotoxic T and NK Cells for Immunotherapy in Chronic Lymphocytic Leukemia.
Hofland T; Eldering E; Kater AP; Tonino SH
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484424
[TBL] [Abstract][Full Text] [Related]
12. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
Bertaina A; Roncarolo MG
Front Immunol; 2019; 10():1342. PubMed ID: 31354695
[TBL] [Abstract][Full Text] [Related]
13. Cellular Therapy in Chronic Lymphocytic Leukemia: Have We Advanced in the Last Decade?
Katz OB; Yehudai-Ofir D; Zuckerman T
Acta Haematol; 2024; 147(1):99-112. PubMed ID: 37812926
[TBL] [Abstract][Full Text] [Related]
14. New insights into hematopoietic stem cell transplantation for chronic lymphocytic leukemia: a 2015 perspective.
McClanahan F; Gribben J
Clin Adv Hematol Oncol; 2015 Sep; 13(9):586-94. PubMed ID: 26452190
[TBL] [Abstract][Full Text] [Related]
15. Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?
Dreger P
Cancer J; 2021 Jul-Aug 01; 27(4):297-305. PubMed ID: 34398556
[TBL] [Abstract][Full Text] [Related]
16. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
Singh N; Frey NV; Grupp SA; Maude SL
Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
[TBL] [Abstract][Full Text] [Related]
17. Immune Therapy for Chronic Lymphocytic Leukemia: Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond.
Shadman M; Maloney DG
Hematol Oncol Clin North Am; 2021 Aug; 35(4):847-862. PubMed ID: 34174989
[TBL] [Abstract][Full Text] [Related]
18. Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.
Faitschuk E; Hombach AA; Frenzel LP; Wendtner CM; Abken H
Blood; 2016 Sep; 128(13):1711-22. PubMed ID: 27535994
[TBL] [Abstract][Full Text] [Related]
19. An update on current and prospective immunotherapies for chronic lymphocytic leukemia.
Emole JN; Locke FL; Pinilla-Ibarz J
Immunotherapy; 2015; 7(4):455-66. PubMed ID: 25917633
[TBL] [Abstract][Full Text] [Related]
20. [Research Progress in Treatment of Chronic Lymphocytic Leukemia --Review].
Zhang R; Xin R; Dou LP; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1910-1915. PubMed ID: 38071082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
